System and method for promoting diuresis and natriuresis by the application of electric fields to the kidney

• US 8,457,761 B2
• Filed: 01/07/2010
• Issued: 06/04/2013
• Est. Priority Date: 01/14/2009
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Wariar, Ramesh
• Primary Examiner(s): Koharski, Christopher D
• Assistant Examiner(s): MAHMOOD, NADIA AHMAD
• Application Number:
  US12/683,553
• Publication Number:
  US 20100179620A1
• Time in Patent Office: 1,244 Days
• Field of Search: 607/68
• US Class Current: 607/68
• CPC Class Codes: A61N 1/306 Arrangements where at least part of the apparatus is introduced into the body
• CPC Class Codes: A61N 1/325 for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body electrodes for external use A61N1/0428
• CPC Class Codes: A61N 1/36007 of urogenital or gastrointestinal organs, e.g. for incontinence control

Abstract

A system and method of applying an electric field to the kidney of a subject can reduce renal salt and water retention through the process of electrophoresis. The system includes a first and a second electrode, at least of which is implantably associated with the kidney. The electric field can be controlled to affect the removal of a first constituent (e.g. sodium) from the kidney while the level of a second constituent (e.g. potassium) is maintained within normal physiological range.

Claims

1. A system comprising:

a first electrode and a second electrode, wherein at least one of the first electrode or the second electrode is implantably associated with a kidney of a subject;

an electric field generator circuit coupled to the first electrode and the second electrode and configured to generate an electric field; and

a controller circuit coupled to the electric field generator circuit and configured to control the electric field between the first and second electrodes, such that, through a process of electrophoresis, an electrophoretic gradient is produced to cause a net migration of a first constituent from a peritubular capillary of the kidney to a tubule associated with the peritubular capillary, wherein the first constituent is removed from the subject and a second constituent is maintained within a specified physiological range.

2. The system of claim 1, further comprising a monitoring circuit configured to monitor a level of the first constituent in the kidney and a level of the second constituent in the kidney.

3. The system of claim 1, wherein the first electrode includes a cathode and is located in or near at least one of a Bowman'"'"'s capsule, a macula densa, a tubule, a collecting duct, a renal pelvis, a ureter, or a urinary bladder.

4. The system of claim 1, wherein the second electrode includes an anode and is located in or near at least one of a renal vein, a renal artery, or a peritubular capillary network.

5. The system of claim 1, wherein the first constituent includes sodium and the second constituent includes potassium.

6. The system of claim 1, wherein the controller circuit is configured to control the electric field to remove water from the kidney.

7. The system of claim 6, wherein the controller circuit is configured to control the electric field to treat a condition of the subject including fluid overload.

8. The system of claim 1, wherein the electric field generator circuit is configured to generate a biphasic voltage pulse comprising a first and a second phase, a magnitude of at least one of the first or the second phase being between about 0.1 Volt and about 20 Volts.

9. The system of claim 1, wherein the electric field generator circuit is configured to generate pulses at a repetition rate that is between about 10 minutes and about 1 microsecond.

10. The system of claim 1, wherein the controller circuit is configured to control at least one of a magnitude, a pulsewidth, a frequency, a duration, or a waveform associated with the electric field using information about at least one of the level of the first or the second constituent.

11. The system of claim 1, wherein the controller circuit is configured to control at least one of a magnitude, a pulsewidth, a frequency, a duration, or a waveform associated with the electric field using information from at least one implanted sensor including an implantable heart sound sensor;

an implantable impedance sensor;

an implantable activity sensor;

an implantable respiration sensor;

an implantable blood pressure sensor;

an implantable electrocardiogram sensor;

an implantable oxygen saturation sensor;

an implantable blood flow sensor;

an implantable temperature sensor;

or an implantable renal conductivity sensor.

12. A method comprising:

applying an electric field to a subject using a first electrode and a second electrode, at least one of the first electrode or the second electrode being implantably associated with a kidney of the subject; and

controlling the electric field between the first and second electrodes, such that, through a process of electrophoresis, an electrophoretic gradient is produced to cause a net migration of a first constituent from a peritubular capillary of the kidney to a tubule associated with the peritubular capillary, wherein the first constituent is removed from the subject and a second constituent is maintained within a specified physiological range.

13. The method of claim 12, further comprising monitoring a level of the first constituent in the kidney and a level of the second constituent in the kidney.

14. The method of claim 12, wherein the applying an electric field includes using the first electrode, including a cathode, in or near at least one of a Bowman'"'"'s capsule, a macula densa, a tubule, a collecting duct, a renal pelvis, a ureter, or a urinary bladder.

15. The method of claim 12, wherein the applying an electric field includes using the second electrode, including an anode, in or near a renal vein, a renal artery, or a peritubular capillary network.

16. The method of claim 12, wherein the first constituent includes sodium and the second constituent includes potassium.

17. The method of claim 12 wherein the controlling the electric field includes removing water from the kidney.

18. The method of claim 17, wherein the removing the water from the kidney includes to treat a condition of the subject including fluid overload.

19. The method of claim 12, wherein the applying an electric field includes providing a biphasic voltage pulse including a first and a second phase, a magnitude of at least one of the first or the second phase being between about 0.1 Volt and about 20 Volts.

20. The method of claim 12, wherein the applying an electric field includes providing pulses at a repetition rate that is between about 10 minutes and about 1 microsecond.

21. The method of claim 12, wherein the controlling the electric field includes controlling at least one of a magnitude, a pulsewidth, a frequency, a duration, or a waveform associated with the electric field using information about at least one of the level of the first constituent or the second constituent.

22. The method of claim 12, wherein the controlling the electric field includes controlling at least one of a magnitude, a pulsewidth, a frequency, a duration, or a waveform associated with the electric field using information from at least one implanted sensor including an implantable heart sound sensor;

an implantable impedance sensor;

an implantable activity sensor;

an implantable respiration sensor;

an implantable blood pressure sensor;

an implantable electrocardiogram sensor;

an implantable oxygen saturation sensor;

an implantable blood flow sensor;

an implantable temperature sensor;

or an implantable renal conductivity sensor.